Abstract: . . .  and companies within the biotechnology and medical device sector. The biosciences have already contributed to the fiscal health of Washington State and the physical health of individuals around the globe. We invite you to work with us to ensure the sector’s continued growth and development. Table 2. State Policy Initiatives in Biosciences, Washington and Other States. Source: Battelle Memorial Institute, State Government Initiatives in Biotechnology , 2001. State Initiative State bioscience strategy Increased state funding of academic biosciences research centers Publicly supported bioscience and venture funds Facilities financing for companies State tax policies State-financed biosciences research parks and incubators Commercialization and business development initiatives for bioscience Workforce development programs Networking X X X . . .
. . .  ITY OF S EATTLE , O FFICE OF E CONOMIC D EVELOPMENT ; E CO - NOMIC D EVELOPMENT C OUNCIL OF S EATTLE & K ING C OUNTY ; I NFO . R ESOURCE , I NC .; NASDAQ; AND S NOHOMISH C OUNTY EDC.  . . .
. . .  growing part of the state’s economy for more than a decade. The ability to continue this growth during the next decade and beyond is contingent on many factors, including: Federal healthcare legisla- tion; the condition of the capital markets; the availability of new technologies and the skilled work force needed to advance them; and economic policy within the State. Business and community leaders throughout the United States (and the world) are increasingly aware of the unfolding opportunities within the BioEconomy. The stakes are high for regions seeking to become competitive bioscience clusters. There are more than 40 regions in the U.S. that have engaged in some form of a life science strategy. These states have taken actions, unmatched by Washington, to attract and retain biotechnology and medical device companies. State initiatives include developing a comprehensive . . .
--3000,3,500,2816,22017